Grasping trimethylation of histone H3 at lysine 4

Epigenomics

Volumn 2, Issue 3, 2010, Pages 395-406

  Vermeulen, Michiel ^a   Timmers, H T Marc ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

chromatin modifications; epigenetics; gene regulation; histone methylation; TFIID

Indexed keywords

DNA; HISTONE; HISTONE H3; LYSINE;

CHROMATIN; CHROMATIN STRUCTURE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBUNIT; EPIGENETICS; GENE CONTROL; GENE EXPRESSION REGULATION; MAMMAL CELL; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SACCHAROMYCES CEREVISIAE; YEAST;

CHROMATIN; DNA METHYLATION; DNA POLYMERASE II; GENE EXPRESSION REGULATION; HISTONES; HUMANS; LYSINE; PROTEIN PROCESSING, POST-TRANSLATIONAL; SACCHAROMYCES CEREVISIAE;

EUKARYOTA;

EID: 77954110394     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.10.11     Document Type: Review

References (130)

1. Kornberg RD, Lorch Y: Twenty-fve years of the nucleosome, fundamental particle of the eukaryote chromosome. Cell 98(3), 285-294 (1999).
2. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ: Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389(6648), 251-260 (1997).
3. Segal E, Widom J: What controls nucleosome positions? Trends Genet. 25(8), 335-343 (2009).
4. Zlatanova J, Bishop TC, Victor JM, Jackson V, van Holde K: The nucleosome family: dynamic and growing. Structure 17(2), 160-171 (2009).
5. Kusch T, Workman JL: Histone variants and complexes involved in their exchange. Subcell. Biochem. 41, 91-109 (2007).
6. Loyola A, Almouzni G: Marking histone H3 variants: how, when and why? Trends Biochem. Sci. 32(9), 425-433 (2007).
7. Svotelis A, Gevry N, Gaudreau L: Regulation of gene expression and cellular proliferation by histone h2a.Z. Biochem. Cell Biol. 87(1), 179-188 (2009).
8. Jin C, Zang C, Wei G et al.: H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nat. Genet. 41(8), 941-945 (2009).
9. Varga-Weisz PD, Becker PB: Regulation of higher-order chromatin structures by nucleosome-remodelling factors. Curr. Opin. Genet. Dev. 16(2), 151-156 (2006).
10. Simon JA, Tamkun JW: Programming off and on states in chromatin: mechanisms of polycomb and trithorax group complexes. Curr. Opin. Genet. Dev. 12(2), 210-218 (2002).
11. Kouzarides T: Chromatin modifcations and their function. Cell 128(4), 693-705 (2007).
12. Strahl BD, Allis CD: The language of covalent histone modifcations. Nature 403(6765), 41-45 (2000).
13. Shahbazian MD, Grunstein M: Functions of site-specifc histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100 (2007).
14. Berger SL: The complex language of chromatin regulation during transcription. Nature 447(7143), 407-412 (2007).
15. Hamamoto R, Furukawa Y, Morita M et al.: Smyd3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell Biol. 6(8), 731-740 (2004).
16. Baker LA, Allis CD, Wang GG: PHD fingers in human diseases: disorders arising from misinterpreting epigenetic marks. Mutat. Res. 647(1-2), 3-12 (2008).
17. Cloos PA, Christensen J, Agger K, Helin K: Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22(9), 1115-1140 (2008).
18. Krivtsov AV, Armstrong SA: MLL translocations, histone modifcations and leukaemia stem-cell development. Nat. Rev. Cancer 7(11), 823-833 (2007).
19. Wang GG, Song J, Wang Z et al.: Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 459(7248), 847-851 (2009).
20. Ruthenburg AJ, Allis CD, Wysocka J: Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell 25(1), 15-30 (2007).
21. Shilatifard A: Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 20(3), 341-348 (2008).
22. Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ: How chromatin-binding modules interpret histone modifcations: lessons from professional pocket pickers. Nat. Struct. Mol. Biol. 14(11), 1025-1040 (2007).
23. Pinskaya M, Morillon A: Histone H3 lysine 4 di-methylation: a novel mark for transcriptional fdelity? Epigenetics 4(5), 302-306 (2009).
24. Dreijerink KM, Lips CJ, Timmers HT: Multiple endocrine neoplasia type 1: a chromatin writer's block. J. Intern. Med. 266(1), 53-59 (2009).
25. Nottke A, Colaiacovo MP, Shi Y: Developmental roles of the histone lysine demethylases. Development 136(6), 879-889 (2009).
26. Sims RJ 3rd, Reinberg D: Histone H3 lys 4 methylation: caught in a bind? Genes Dev. 20(20), 2779-2786 (2006).
27. Santos-Rosa H, Schneider R, Bannister AJ et al.: Active genes are tri-methylated at K4 of histone H3. Nature 419(6905), 407-411 (2002).
28. Strahl BD, Grant PA, Briggs SD et al.: Set2 is a nucleosomal histone H3-selective methyltransferase that mediates transcriptional repression. Mol. Cell Biol 22(5), 1298-1306 (2002).
29. Hampsey M, Reinberg D: Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation. Cell 113(4), 429-432 (2003).
30. Pijnappel W W, Schaft D, Roguev A et al.: The S. cerevisiae set3 complex includes two histone deacetylases, hos2 and hst1, and is a meiotic-specifc repressor of the sporulation gene program. Genes Dev. 15(22), 2991-3004 (2001).
31. van Leeuwen F, Gafken PR, Gottschling DE: Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 109(6), 745-756 (2002).
32. Pokholok DK, Harbison CT, Levine S et al.: Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122(4), 517-527 (2005).
33. Couture JF, Collazo E, Hauk G, Trievel RC: Structural basis for the methylation site specifcity of set7/9. Nat. Struct. Mol. Biol. 13(2), 140-146 (2006).
34. Takahashi YH, Lee JS, Swanson SK et al.: Regulation of H3K4 trimethylation via CPS40 (SPP1) of compass is monoubiquitination independent: implication for a PHE/TYR switch by the catalytic domain of set1. Mol. Cell Biol. 29(13), 3478-3486 (2009).
35. Miller T, Krogan NJ, Dover J et al.: COMPASS: a complex of proteins associated with a trithorax-related set domain protein. Proc. Natl Acad. Sci. USA 98(23), 12902-12907 (2001).
36. Roguev A, Schaft D, Shevchenko A et al.: The Saccharomyces cerevisiae set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4. EMBO J. 20(24), 7137-7148 (2001).
37. Sun ZW, Allis CD: Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418(6893), 104-108 (2002).
38. Lee JS, Shukla A, Schneider J et al.: Histone crosstalk between H2B monoubiquitination and H3 methylation mediated by COMPASS. Cell 131(6), 1084-1096 (2007).
39. Vitaliano-Prunier A, Menant A, Hobeika M, Geli V, Gwizdek C, Dargemont C: Ubiquitylation of the compass component SWD2 links H2B ubiquitylation to H3K4 trimethylation. Nat. Cell Biol. 10(11), 1365-1371 (2008).
40. South PF, Fingerman IM, Mersman DP, Du HN, Briggs SD: A conserved interaction between the SDI domain of Bre2 and the Dpy-30 domain of Sdc1 is required for histone methylation and gene expression. J. Biol. Chem. 285(1), 595-607 (2010).
41. Barski A, Cuddapah S, Cui K et al.: High-resolution profling of histone methylations in the human genome. Cell 129(4), 823-837 (2007).
42. Bernstein BE, Kamal M, Lindblad-Toh K et al.: Genomic maps and comparative analysis of histone modifcations in human and mouse. Cell 120(2), 169-181 (2005).
43. Heintzman ND, Stuart RK, Hon G et al.: Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39(3), 311-318 (2007).
44. Heintzman ND, Hon GC, Hawkins RD et al.: Histone modifcations at human enhancers refect global cell-type-specifc gene expression. Nature 459(7243), 108-112 (2009).
45. Bernstein BE, Mikkelsen TS, Xie X et al.: A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125(2), 315-326 (2006).
46. Mikkelsen TS, Ku M, Jaffe DB et al.: Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448(7153), 553-560 (2007).
47. Roh TY, Wei G, Farrell CM, Zhao K: Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res. 17(1), 74-81 (2007).
48. Pietersen AM, van Lohuizen M: Stem cell regulation by polycomb repressors: postponing commitment. Curr. Opin. Cell Biol. 20(2), 201-207 (2008).
49. Creyghton MP, Markoulaki S, Levine SS et al.: H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 135(4), 649-661 (2008).
50. Guenther MG, Levine SS, Boyer LA, Jaenisch R, Young RA: A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130(1), 77-88 (2007).
51. Guttman M, Amit I, Garber M et al.: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458(7235), 223-227 (2009).
52. Barski A, Jothi R, Cuddapah S et al.: Chromatin poises miRNA-and protein-coding genes for expression. Genome Res. 19(10), 1742-1751 (2009).
53. Dillon SC, Zhang X, Trievel RC, Cheng X: The set-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 6(8), 227 (2005).
54. Hughes CM, Rozenblatt-Rosen O, Milne TA et al.: Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol. Cell 13(4), 587-597 (2004).
55. Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W: Human sin3 deacetylase and trithorax-related set1/ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor hcf-1. Genes Dev. 17(7), 896-911 (2003).
56. Yokoyama A, Wang Z, Wysocka J et al.: Leukemia proto-oncoprotein MLL forms a set1-like histone methyltransferase complex with menin to regulate hox gene expression. Mol. Cell Biol. 24(13), 5639-5649 (2004).
57. Cho YW, Hong T, Hong S et al.: PTIP associates with MLL3-and MLL4-containing histone H3 lysine 4 methyltransferase complex. J. Biol. Chem. 282(28), 20395-20406 (2007).
58. Lee JH, Tate CM, You JS, Skalnik DG: Identifcation and characterization of the human set1b histone H3-Lys4 methyltransferase complex. J. Biol. Chem. 282(18), 13419-13428 (2007).
59. Lee MG, Villa R, Trojer P et al.: Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318(5849), 447-450 (2007).
60. Ng HH, Robert F, Young RA, Struhl K: Targeted recruitment of set1 histone methylase by elongating pol II provides a localized mark and memory of recent transcriptional activity. Mol. Cell 11(3), 709-719 (2003).
61. Buratowski S: Progression through the RNA polymerase II CTD cycle. Mol. Cell 36(4), 541-546 (2009).
62. Guenther MG, Jenner RG, Chevalier B et al.: Global and hox-specifc roles for the MLL1 methyltransferase. Proc. Natl Acad. Sci. USA 102(24), 8603-8608 (2005).
63. Wu M, Wang PF, Lee JS et al.: Molecular regulation of H3K4 trimethylation by WDR82, a component of human set1/compass. Mol. Cell Biol. 28(24), 7337-7344 (2008).
64. Lee JH, Skalnik DG: WDR82 is a C-terminal domain-binding protein that recruits the SETD1A histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes. Mol. Cell Biol. 28(2), 609-618 (2008).
65. Schlichter A, Cairns BR: Histone trimethylation by SET1 is coordinated by the RRM, autoinhibitory, and catalytic domains. EMBO J. 24(6), 1222-1231 (2005).
66. Ayton PM, Cleary ML: Transformation of myeloid progenitors by MLL oncoproteins is dependent on HOXA7 and HOXA9. Genes Dev. 17(18), 2298-2307 (2003).
67. Wang P, Lin C, Smith ER et al.: Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol. Cell Biol. 29(22), 6074-6085 (2009).
68. Blobel GA, Kadauke S, Wang E et al.: A reconfgured pattern of MLL occupancy within mitotic chromatin promotes rapid transcriptional reactivation following mitotic exit. Mol. Cell 36, 970-983 (2009).
69. Chandrasekharappa SC, Guru SC, Manickam P et al.: Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276(5311), 404-407 (1997).
70. Dreijerink KM, Mulder KW, Winkler GS, Hoppener JW, Lips CJ, Timmers HT: Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res. 66(9), 4929-4935 (2006).
71. Dreijerink KM, Varier RA, van Beekum O et al.: The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor y-dependent adipocyte differentiation. Mol. Cell Biol. 29(18), 5060-5069 (2009).
72. Imachi H, Murao K, Dobashi H et al.: Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance. Breast Cancer Res. Treat. DOI: 10.1007/s10549-009-0581-590 (2009) (Epub ahead of print).
73. Mo R, Rao SM, Zhu YJ: Identifcation of the MLL2 complex as a coactivator for estrogen receptor a. J. Biol. Chem. 281(23), 15714-15720 (2006).
74. Sierra J, Yoshida T, Joazeiro CA, Jones KA: The APC tumor suppressor counteracts p-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 20(5), 586-600 (2006).
75. Tyagi S, Chabes AL, Wysocka J, Herr W: E2f activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Mol. Cell 27(1), 107-119 (2007).
76. Kim DH, Lee J, Lee B, Lee JW: Ascom controls farnesoid X receptor transactivation through its associated histone H3 lysine 4 methyltransferase activity. Mol. Endocrinol. 23(10), 1556-1562 (2009).
77. Lee J, Kim DH, Lee S et al.: A tumor suppressive coactivator complex of p53 containing asc-2 and histone H3-Lysine 4 methyltransferase MLL3 or its paralogue MLL4. Proc. Natl Acad. Sci. USA 106(21), 8513-8518 (2009).
78. Shi Y, Lan F, Matson C et al.: Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119(7), 941-953 (2004).
79. Allis CD, Berger SL, Cote J et al.: New nomenclature for chromatin-modifying enzymes. Cell 131(4), 633-636 (2007).
80. Pasini D, Hansen KH, Christensen J, Agger K, Cloos PA, Helin K: Coordinated regulation of transcriptional repression by the RBP2 H3K4 demethylase and polycomb-repressive complex 2. Genes Dev. 22(10), 1345-1355 (2008).
81. Tahiliani M, Mei P, Fang R et al.: The histone H3K4 demethylase SMCX links rest target genes to X-linked mental retardation. Nature 447(7144), 601-605 (2007).
82. Iwase S, Lan F, Bayliss P et al.: The x-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell 128(6), 1077-1088 (2007).
83. Klose RJ, Yan Q, Tothova Z et al.: The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128(5), 889-900 (2007).
84. Lee MG, Norman J, Shilatifard A, Shiekhattar R: Physical and functional association of a trimethyl H3K4 demethylase and RING6A/MBLR, a polycomb-like protein. Cell 128(5), 877-887 (2007).
85. Horton JR, Upadhyay AK, Qi HH, Zhang X, Shi Y, Cheng X: Enzymatic and structural insights for substrate specifcity of a family of jumonji histone lysine demethylases. Nat. Struct. Mol. Biol. 17(1), 38-43 (2009).
86. Radman-Livaja M, Liu CL, Friedman N, Schreiber SL, Rando OJ: Replication and active demethylation represent partially overlapping mechanisms for erasure of H3K4me3 in budding yeast. PLoS Genet. 6(2), E1000837 (2010).
87. Zee BM, Levin RS, Xu B, Leroy G, Wingreen NS, Garcia BA: In vivo residue-specifc histone methylation dynamics. J. Biol. Chem. 285(5), 3341-3350 (2010).
88. Clayton AL, Hazzalin CA, Mahadevan LC: Enhanced histone acetylation and transcription: a dynamic perspective. Mol. Cell 23(3), 289-296 (2006).
89. Wang Z, Zang C, Cui K et al.: Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138(5), 1019-1031 (2009).
90. Lopez-Bigas N, Kisiel TA, Dewaal DC et al.: Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation. Mol. Cell 31(4), 520-530 (2008).
91. Vermeulen M, Mulder KW, Denissov S et al.: Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131(1), 58-69 (2007).
92. Vermeulen M, Hubner NC, Mann M: High confdence determination of specifc protein-protein interactions using quantitative mass spectrometry. Curr. Opin. Biotechnol. 19(4), 331-337 (2008).
93. Shi X, Hong T, Walter KL et al.: ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442(7098), 96-99 (2006).
94. Sharma K, Weber C, Bairlein M et al.: Proteomics strategy for quantitative protein interaction profling in cell extracts. Nat. Methods 6(10), 741-744 (2009).
95. Saksouk N, Avvakumov N, Champagne KS et al.: Hbo1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail. Mol. Cell 33(2), 257-265 (2009).
96. Wysocka J, Swigut T, Xiao H et al.: A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 442(7098), 86-90 (2006)
97. Sims RJ 3rd, Millhouse S, Chen CF et al.: Recognition of trimethylated histone H3 lysine 4 facilitates the recruitment of transcription postinitiation factors and pre-mRNA splicing. Mol. Cell 28(4), 665-676 (2007).
98. Lee J, Thompson JR, Botuyan M V, Mer G: Distinct binding modes specify the recognition of methylated histones H3K4 and H4k20 by JMJD2A-tudor. Nat. Struct. Mol. Biol. 15(1), 109-111 (2008).
99. Shin S, Janknecht R: Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 353(4), 973-977 (2007).
100. Matthews AG, Kuo AJ, Ramon-Maiques S et al.: Rag2 PHD finger couples histone H3 lysine 4 trimethylation with v(d)j recombination. Nature 450(7172), 1106-1110 (2007).
101. Albright SR, Tjian R: TAFs revisited: more data reveal new twists and confrm old ideas. Gene 242(1-2), 1-13 (2000).
102. Cler E, Papai G, Schultz P, Davidson I: Recent advances in understanding the structure and function of general transcription factor TFIID. Cell Mol. Life Sci. 66(13), 2123-2134 (2009).
103. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM, Gudkov AV: The candidate tumour suppressor p33ing1 cooperates with p53 in cell growth control. Nature 391(6664), 295-298 (1998).
104. Juven-Gershon T, Hsu JY, Theisen J W, Kadonaga JT: The RNA polymerase II core promoter-the gateway to transcription. Curr. Opin. Cell Biol. 20(3), 253-259 (2008).
105. Sandelin A, Carninci P, Lenhard B, Ponjavic J, Hayashizaki Y, Hume DA: Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nat. Rev. Genet. 8(6), 424-436 (2007).
106. Tu S, Teng YC, Yuan C et al.: The arid domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif. Nat. Struct. Mol. Biol. 15(4), 419-421 (2008).
107. Huang Y, Fang J, Bedford MT, Zhang Y, Xu RM: Recognition of histone H3 lysine 4 methylation by the double tudor domain of jmjd2a. Science 312(5774), 748-751 (2006).
108. Kim T, Buratowski S: Dimethylation of H3K4 by set1 recruits the set3 histone deacetylase complex to 5́ transcribed regions. Cell 137(2), 259-272 (2009).
109. Wang Z, Zang C, Rosenfeld JA et al.: Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40(7), 897-903 (2008).
110. Guccione E, Bassi C, Casadio F et al.: Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 449(7164), 933-937 (2007).
111. Guccione E, Martinato F, Finocchiaro G et al.: Myc-binding-site recognition in the human genome is determined by chromatin context. Nat. Cell Biol. 8(7), 764-770 (2006).
112. Hyllus D, Stein C, Schnabel K et al.: Prmt6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev. 21(24), 3369-3380 (2007).
113. Iberg AN, Espejo A, Cheng D et al.: Arginine methylation of the histone H3 tail impedes effector binding. J. Biol. Chem. 283(6), 3006-3010 (2008).
114. Kirmizis A, Santos-Rosa H, Penkett CJ et al.: Arginine methylation at histone H3R2 controls deposition of H3K4 trimethylation. Nature 449(7164), 928-932 (2007).
115. Ramon-Maiques S, Kuo AJ, Carney D et al.: The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine 4 and arginine-2. Proc. Natl Acad. Sci. USA 104(48), 18993-18998 (2007).
116. Dai J, Sultan S, Taylor SS, Higgins JM: The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes Dev. 19(4), 472-488 (2005).
117. Kang TH, Park DY, Choi YH, Kim KJ, Yoon HS, Kim KT: Mitotic histone H3 phosphorylation by vaccinia-related kinase 1 in mammalian cells. Mol. Cell Biol. 27(24), 8533-8546 (2007).
118. Fischle W, Tseng BS, Dormann HL et al.: Regulation of hp1-chromatin binding by histone H3 methylation and phosphorylation. Nature 438(7071), 1116-1122 (2005).
119. Mateescu B, England P, Halgand F, Yaniv M, Muchardt C: Tethering of HP 1 proteins to chromatin is relieved by phosphoacetylation of histone H3. EM BO Rep. 5(5), 490-496 (2004).
120. Albert I, Mavrich TN, Tomsho LP et al.: Translational and rotational settings of h2a.Z nucleosomes across the Saccharomyces cerevisiae genome. Nature 446(7135), 572-576 (2007).
121. Mavrich TN, Jiang C, Ioshikhes IP et al.: Nucleosome organization in the drosophila genome. Nature 453(7193), 358-362 (2008).
122. Altaf M, Auger A, Covic M, Cote J: Connection between histone H2a variants and chromatin remodeling complexes. Biochem. Cell Biol. 87(1), 35-50 (2009).
123. Taverna SD, Ueberheide BM, Liu Y et al.: Long-distance combinatorial linkage between methylation and acetylation on histone H3 N termini. Proc. Natl Acad. Sci. USA 104(7), 2086-2091 (2007).
124. Young NL, Dimaggio PA, Plazas-Mayorca MD, Baliban RC, Floudas CA, Garcia BA: High throughput characterization of combinatorial histone codes. Mol. Cell Proteomics 8(10), 2266-2284 (2009).
125. Mcginty RK, Kim J, Chatterjee C, Roeder RG, Muir TW: Chemically ubiquitylated histone H2b stimulates hdot1l-mediated intranucleosomal methylation. Nature 453(7196), 812-816 (2008).
126. Simon MD, Chu F, Racki LR et al.: The site-specifc installation of methyl-lysine analogs into recombinant histones. Cell 128(5), 1003-1012 (2007).
127. Chang Y, Zhang X, Horton JR et al.: Structural basis for G9A-like protein lysine methyltransferase inhibition by bix-01294. Nat. Struct. Mol. Biol. 16(3), 312-317 (2009).
128. Quinn AM, Bedford MT, Espejo A et al.: A homogeneous method for investigation of methylation-dependent protein-protein interactions in epigenetics. Nucleic Acids Res. 38(2), E11 (2010).
129. Spannhoff A, Hauser AT, Heinke R, Sippl W, Jung M: The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors. ChemMedChem. 4(10), 1568-1582 (2009).
130. Savitski MM, Nielsen ML, Zubarev RA: Modifcomb, a new proteomic tool for mapping substoichiometric post-translational modifcations, finding novel types of modifcations, and fingerprinting complex protein mixtures. Mol. Cell Proteomics 5(5), 935-948 (2006).